Your browser doesn't support javascript.
loading
Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma.
Kamada, Shuhei; Ikeda, Kazuhiro; Suzuki, Takashi; Sato, Wataru; Kitayama, Sachi; Kawakami, Satoru; Ichikawa, Tomohiko; Horie, Kuniko; Inoue, Satoshi.
Afiliación
  • Kamada S; Division of Systems Medicine & Gene Therapy, Saitama Medical University, Saitama, Japan.
  • Ikeda K; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Suzuki T; Division of Systems Medicine & Gene Therapy, Saitama Medical University, Saitama, Japan.
  • Sato W; Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Kitayama S; Division of Systems Medicine & Gene Therapy, Saitama Medical University, Saitama, Japan.
  • Kawakami S; Division of Systems Medicine & Gene Therapy, Saitama Medical University, Saitama, Japan.
  • Ichikawa T; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Horie K; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Inoue S; Division of Systems Medicine & Gene Therapy, Saitama Medical University, Saitama, Japan.
Front Oncol ; 11: 758503, 2021.
Article en En | MEDLINE | ID: mdl-34804954

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza